Healthcare, Bioethics, and Christian Investing

Introduction: Navigating the Most Complex Screening Area in Christian Investing

Healthcare and bioethics present the most complex and theologically fraught screening area in Christian investing. Unlike gambling (where Christian consensus is broad) or weapons (where ethical concerns are clear), healthcare touches fundamental questions about suffering, life, death, medical ethics, and the nature of human flourishing. Different Christian traditions reach substantially different conclusions about which healthcare companies are appropriate investments.

This complexity arises because healthcare involves genuine moral trade-offs. A pharmaceutical company developing life-saving treatments may also produce contraceptive products. A hospital system may provide compassionate end-of-life care while also offering elective abortions. A medical device manufacturer may create prosthetics for disabled patients while also supplying abortion equipment.

This guide explores healthcare screening in Christian investing, examining key bioethical issues, how different Christian traditions approach them, and practical frameworks for investors to navigate these complex terrain.

Key Bioethical Issues in Healthcare Investing

Several major bioethical issues shape Christian screening of healthcare companies:

Abortion and Abortion-Related Products

Abortion is the most polarizing bioethical issue in healthcare investing. Different Christian traditions hold dramatically different views on abortion.

Catholic and evangelical perspectives: The Catholic Church teaches that abortion is immoral from conception. Evangelical Christians and some other Protestant traditions similarly oppose abortion. From these perspectives, companies that produce abortion drugs or equipment, or that perform or facilitate abortions, are morally problematic investments.

The abortion pill (mifepristone): The medication mifepristone (also called RU-486 or branded as Mifeprex) is a progesterone antagonist that induces miscarriage when taken in the early stages of pregnancy. Danco Laboratories, owned by GenBiologics, produces Mifeprex, the only FDA-approved brand of mifepristone in the United States. Christian funds that screen against abortion typically exclude companies involved in mifepristone production or distribution.

Mainline Protestant and other perspectives: Mainline Protestant denominations, many Jewish traditions, and other Christian groups take different positions, often supporting access to abortion as part of women’s healthcare rights. From these perspectives, opposing companies that provide abortion services is inappropriate government or institutional overreach into personal medical decisions.

This fundamental disagreement means no single “Christian” screening standard exists for abortion-related products. Investors must align screening with their own theological convictions.illing a calling, and view treatment of disease as moral good. The ethical complexity arises not from the goal of healthcare but from the means: which therapies, which procedures, and which philosophical frameworks guide treatment decisions?

Contraception: Christian perspectives on contraception vary significantly. Catholic teaching opposes contraception, viewing it as contrary to natural law and the procreative purpose of sexual intercourse. Many evangelical and Protestant Christians accept contraception as morally acceptable. This disagreement affects screening: Catholic funds screen out contraceptive manufacturers; many other Christian funds do not.

The result is that a company like pharmaceutical giant Johnson & Johnson, which produces both life-saving cancer drugs and birth control products, is screened out by some Christian funds as inappropriate but acceptable to others.

End-of-Life Care and Assisted Suicide

Healthcare companies may be involved in end-of-life care including physician-assisted suicide. Oregon, California, and other states have legalized physician-assisted suicide for terminally ill patients. Some companies may provide drugs, equipment, or services for these procedures.

Christian perspectives: Catholic, evangelical, and traditional Protestant teaching holds that human life should not be deliberately ended. From this perspective, companies facilitating assisted suicide conflict with Christian values. However, other Christian traditions view end-of-life decisions differently, emphasizing compassion, relief from suffering, and patient autonomy.

Again, this represents genuine disagreement among thoughtful Christians about how to navigate suffering and death.

Genetic Engineering and Gene Therapy

New technologies in genetic engineering, CRISPR gene editing, and gene therapy raise profound questions about human nature, disability, and the boundaries of medical treatment. Christian perspectives on these technologies vary widely.istone (branded as Mifeprex and RU-486) is a progesterone antagonist that interrupts pregnancy by blocking progesterone, which is necessary to maintain pregnancy. For Christian investors opposed to abortion, this product presents a clear screening threshold. Funds that screen out abortion-related companies exclude Danco/GenBiologics.

Partial or selective exclusions: Some Christian funds take a nuanced approach, excluding only direct producers of abortion drugs and equipment, but not general pharmaceutical companies that may have reproductive health divisions. The logic: a pharmaceutical company that makes diabetes drugs, heart medications, and birth control occupies a different ethical category than a company dedicated to abortion services.

No specific screening: Some Christian-oriented funds don’t screen specifically for abortion-related products, instead focusing on other values (environmental, labor, governance) while trusting investors to make personal decisions about abortion-related investments.

These different approaches reflect genuine theological disagreement among Christians about how deeply to screen and what threshold is appropriate.

Screening Methodology and Implementation

Different Christian fund managers take different approaches to healthcare screening:

• Negative screening: Exclude companies engaged in specific practices deemed morally problematic (abortion provision, contraceptive manufacture, etc.)
• Positive screening: Prioritize companies with strong records on health equity, care for vulnerable populations, or transparent ethical frameworks
• Engagement: Hold shares and actively engage with companies to encourage ethical practices rather than divesting
• Hybrid approaches: Combine exclusionary and engagement strategies

Fund managers also grapple with threshold questions: If a company’s revenue is 1% from abortion services, is it excludable? 5%? 20%? Different funds set different thresholds, reflecting different balances between ethical concerns and practical investment realities.

Different Christian Perspectives on Healthcare Investing

Major Christian traditions approach healthcare investing differently, reflecting their theological and ethical commitments. philosophy.

Screening Methodology: Catholic Funds

Catholic funds typically implement comprehensive bioethical screening based on Catholic social teaching. This typically excludes:

• Companies providing abortion services or abortion drugs
• Contraceptive manufacturers and distributors
• Companies involved in assisted suicide or euthanasia
• Embryonic stem cell research companies

Catholic screening represents one of the most comprehensive approaches to healthcare bioethics in Christian investing, reflecting centuries of Catholic moral theology.

Evangelical Approaches

Evangelical Christian funds vary more widely, though many implement anti-abortion screening. Some evangelical funds screen similarly to Catholic funds; others take less comprehensive approaches, focusing on abortion specifically while permitting contraceptive manufacturers.

Evangelical theology traditionally emphasizes personal conscience and conversion, which can lead to more individualized approaches to values-based investing rather than comprehensive institutional screening.

Mainline Protestant Perspectives

Mainline Protestant denominations (Presbyterian Church USA, United Methodist Church, ELCA Lutheran Church) often emphasize different screening priorities. Rather than excluding abortion providers or contraceptive manufacturers, mainline Protestant funds may prioritize:

• Healthcare access for vulnerable populations
• Transparency in drug pricing
• Labor practices in healthcare
• Environmental sustainability in healthcare facilities

This represents a different values framework: rather than negative screening of specific practices, mainline Protestants sometimes focus on positive engagement for health equity and justice.

Practical Framework for Individual Investors

Given this diversity, how should individual Christian investors approach healthcare screening? Here’s a framework:nt screening standards across the faith community. This represents a genuine and important pluralism: Christians of good faith, working from serious theological commitments, reach different conclusions about which companies deserve Christian investor capital.

Your task as a Christian investor is not to find “the” right answer (which may not exist) but to find the framework that aligns with your theological convictions and your understanding of Christian responsibility in investing.

Step 1: Clarify Your Theological Convictions

Begin by examining what you actually believe about the key bioethical issues:

• Abortion: Do you believe abortion is morally wrong? If so, does that conviction extend to excluding investors in companies that provide abortion services? What about companies that provide other reproductive health services?
• Contraception: Do you view contraception as morally problematic? If so, should you exclude contraceptive manufacturers?
• End-of-life care: What are your convictions about assisted suicide and physician-assisted death? Should companies involved in these practices be excluded?
• Research ethics: What are your convictions about genetic engineering, embryonic stem cell research, and other research methodologies?

These aren’t easy questions, but they’re foundational. Your investment choices should flow from your actual theological convictions, not from default assumptions or unexamined cultural positions.

Step 2: Research Fund Screening Practices

Once you’ve clarified your convictions, research what specific Christian funds do. Most funds publish their screening criteria. Review the prospectus or values statement. Call the fund company and ask directly: “Which healthcare companies do you exclude and why?”

Some funds publish comprehensive screening lists showing which healthcare companies they exclude. Others are more vague. If a fund won’t tell you their screening methodology, that’s a red flag—good fund managers should be transparent about their values-based investing criteria.

Step 3: Assess Your Own Holdings

Check what healthcare companies you own through your current investments. Major broad-market index funds hold significant healthcare positions, often including companies with controversial practices.

If you own healthcare stocks that conflict with your convictions, you have choices:

• Move to screened funds: Switch to funds that implement healthcare screening aligned with your values
• Engage with companies: Use shareholder activism to encourage ethical practices rather than divesting
• Accept compromise: If the financial benefits of broad-market investing outweigh your concerns, own the decision consciously

Again, the goal is conscious choice aligned with your convictions, not passive acceptance.

Step 4: Embrace the Complexity and Ambiguity

Healthcare investing forces Christians to grapple with genuine moral complexity. Unlike gambling (clearly problematic) or weapons (clear ethical concerns), healthcare involves real trade-offs. Life-saving cancer drugs may come from companies that also produce contraception. End-of-life care reflects genuine Christian compassion even when combined with physician-assisted suicide.

This complexity is not a failure of Christian ethics; it’s a reality of living in a fallen world where genuine goods are mixed with genuine problems. What matters is that you engage the complexity consciously rather than pretending it doesn’t exist.

Step 5: Revisit Your Choices Periodically

Healthcare technology and practice are rapidly evolving. New ethical issues emerge. Your theological understanding may develop. CRISPR and gene editing technologies that barely existed five years ago now raise profound questions. Your healthcare screening should evolve alongside these changes.

Conclusion: Thoughtful Stewardship in Complexity

Healthcare investing presents Christians with the most complex bioethical questions in values-based investing. Unlike gambling or weapons, healthcare doesn’t present a single “Christian” answer. Instead, it requires prayerful discernment, theological reflection, and careful attention to the specific practices you’re uncomfortable funding.

The goal is not to achieve perfect ethical purity (impossible in a fallen world) but to ensure that your investment choices:

• Reflect your actual theological convictions
• Involve conscious deliberation rather than passive defaults
• Acknowledge the genuine complexity and trade-offs involved
• Include periodic review and reassessment

This approach represents genuine Christian stewardship: thoughtful management of resources that honors God’s call to both wisdom and compassion, even in the face of difficult ethical choices.